The FDA initially added semaglutide injection products for Wegovy and Ozempic to its drug shortage list in March 2022 and August 2022, respectively, and now openly states the shortage has been ongoing for some time. The demand for semaglutide injection products in the United States exceeded the existing supply, and the resulting spur of activity we have seen by 503A compounding pharmacies and 503B outsourcing facilities since then has had an industry-wide impact
All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their contribution to this manuscript
Weight loss during this phase typically averages 1.5-2.5 lbs weekly, with the majority coming from fat stores
The best choice depends on your individual needs, and for many patients, the optimal approach evolves over time as goals and responses change
Daily Lifestyle and Inflammatory Skin Diseases
L-carnitine is a nutrient and dietary supplement